STOCK TITAN

Veradigm Selects MedAllies as its Qualified Health Information Network™ (QHIN™ ) Partner

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
MedAllies (NASDAQ: MDRX) partners with Veradigm Inc. to improve interoperability and treatment decisions for healthcare providers using Veradigm's EHRs. The partnership aims to provide access to longitudinal patient records, medical history, and medication lists, resulting in better point-of-care decision-making and improved interoperability throughout the healthcare industry.
Positive
  • None.
Negative
  • None.

Insights

The partnership between Veradigm Inc. and MedAllies to utilize Qualified Health Information Networks (QHINs) is a strategic move that could significantly enhance the interoperability of electronic health records (EHRs). By facilitating access to comprehensive patient data, healthcare providers can make more informed decisions, potentially leading to improved patient outcomes and more efficient healthcare delivery.

Interoperability has been a long-standing challenge in healthcare IT, often leading to fragmented care and inefficiencies. The integration of QHINs aims to bridge the gaps between disparate health information systems. This could result in a reduction of duplicative tests and procedures, ultimately driving down healthcare costs. Moreover, the ability to access a patient's medical history and medication lists promptly could lead to better management of chronic diseases and more personalized care.

For stakeholders, this partnership may translate into increased trust in Veradigm's EHR solutions, potentially boosting its market share. For the healthcare industry at large, such collaborations are pivotal in moving towards a more connected and patient-centered care model.

The designation of MedAllies as a Qualified Health Information Network under the Trusted Exchange Framework and Common Agreement (TEFCA) signifies a commitment to national standards for data exchange. This regulatory framework is designed to ensure that health information networks operate under common principles and agreements, which is crucial for protecting patient privacy and ensuring data security.

Adherence to TEFCA standards by entities such as MedAllies and Veradigm can foster greater confidence among patients and providers in the secure exchange of health information. This is particularly relevant in the context of rising concerns about data breaches and cybersecurity threats in the healthcare sector. By aligning with these standards, Veradigm is positioning itself as a compliant and responsible actor in the healthcare data ecosystem, which may enhance its reputation and competitive advantage.

Furthermore, the successful implementation of QHINs could serve as a model for other healthcare networks, potentially influencing future policy developments and setting a precedent for how health data interoperability is handled on a national scale.

The collaboration between Veradigm and MedAllies reflects a growing trend in the healthcare industry towards data-driven solutions. The demand for EHR systems that can seamlessly integrate with broader health information networks is on the rise, driven by the need for better data analytics and patient care coordination.

From a market perspective, Veradigm's decision to partner with a QHIN provider could be seen as a response to the competitive pressures in the healthcare IT sector. By enhancing its EHR offerings with robust interoperability features, Veradigm may be able to differentiate itself from competitors and attract new customers. The move could also open up new revenue streams through the provision of additional services such as document retrieval and record location.

Long-term, this partnership could contribute to shaping industry standards for interoperability, influencing the development of future healthcare technologies and potentially leading to market consolidation around a set of common data exchange protocols.

Providers using Veradigm EHRs to gain access to longitudinal patient records, improving interoperability and driving better treatment decisions

FISHKILL, N.Y. and CHICAGO, Ill., Jan. 9, 2024 /PRNewswire/ -- MedAllies, a leading healthcare interoperability and connectivity services provider, announced today that Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology services, has selected MedAllies as its Qualified Health Information Network (QHIN) partner.

The effort will enable providers using Veradigm's EHRs to gain access to a wider range of patient data, including medical history and medication lists, to drive improved point-of-care decision-making, resulting in the closure of more care gaps, and ultimately creating better interoperability throughout the healthcare industry.

MedAllies was recently awarded designation as a QHIN under the Trusted Exchange Framework and Common AgreementSM  (TEFCASM ). QHINs connect directly to each other to ensure interoperability between the networks they represent, enabling healthcare stakeholders to securely and reliably share accurate patient data, driving more informed patient-care decisions.

"As a provider of healthcare data and technology solutions, it is essential that we offer a seamless connection to multiple national health information networks," said Tom Langan, President, and Chief Commercial Officer of Veradigm. "As part of the Veradigm Network's dynamic community of companies providing advanced insights, technology, and data-driven solutions, MedAllies connectivity services help ensure that we can provide our clients with a secure, reliable, and trustworthy source of critical patient data. The platform's document retrieval and record location services help ensure that our clients can quickly and easily access the information they need to guide better patient care decisions."

"QHINs are poised to play an essential role in ushering in a new era of improved interoperability across the healthcare system, resulting in enhanced collaboration for providers and higher-quality care for patients," said John Blair, MD, CEO, MedAllies. "We are proud to work with Veradigm to enable providers to more efficiently and effectively share critical patient information."

About MedAllies

MedAllies plays an indispensable role in ensuring the secure transmission of critical health information, promoting high-quality patient care through national networks that enable seamless data sharing and interoperability among healthcare constituents. We are committed to delivering exceptional network and service quality. Our industry-leading technology sets the standard for integration, message delivery success, document retrieval, patient record location, data usability, and directory accuracy. We serve over 800 hospitals, 5,000 organizations, and 125,000 healthcare providers and collaborate with numerous partners, bringing together millions of stakeholders and cultivating a more streamlined, patient-centered healthcare experience. For more information, visit MedAllies.com and follow us on X and Linkedin.

About Veradigm

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedInFacebookTwitter, and YouTube.

Media Contact for MedAllies
Michelle Ronan Noteboom
Amendola Communications
mnoteboom@acmarketingpr.com 

Media Contact for Veradigm
Concetta Rasiarmos

Concetta.rasiarmos@veradigm.com 

Contact for Investors:
Jenny Gelinas

jenny.gelinas@veradigm.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/veradigm-selects-medallies-as-its-qualified-health-information-network-qhin--partner-302029090.html

SOURCE MedAllies

FAQ

What is the partnership between MedAllies and Veradigm Inc.?

The partnership aims to improve interoperability and treatment decisions for healthcare providers using Veradigm's EHRs, providing access to longitudinal patient records, medical history, and medication lists.

What are the benefits of the partnership for healthcare providers?

The partnership aims to improve point-of-care decision-making and drive better treatment decisions, resulting in the closure of more care gaps and ultimately creating better interoperability throughout the healthcare industry.

What is the role of QHINs in the healthcare system?

QHINs are poised to play an essential role in ushering in a new era of improved interoperability across the healthcare system, resulting in enhanced collaboration for providers and higher-quality care for patients.

What services does MedAllies provide as a QHIN partner?

MedAllies provides connectivity services to enable providers using Veradigm's EHRs to gain access to a wider range of patient data, including medical history and medication lists, to drive improved point-of-care decision-making.

How does the partnership benefit Veradigm's clients?

The partnership ensures that Veradigm's clients can quickly and easily access critical patient data to guide better patient care decisions, providing a secure, reliable, and trustworthy source of information.

Who is the President and Chief Commercial Officer of Veradigm?

Tom Langan is the President and Chief Commercial Officer of Veradigm.

Who is the CEO of MedAllies?

John Blair, MD, is the CEO of MedAllies.

VERADIGM INC

OTC:MDRX

MDRX Rankings

MDRX Latest News

MDRX Stock Data

1.15B
105.42M
1.12%
23.22%
Health Information Services
Healthcare
Link
United States of America
Chicago